nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—DDC—Dopamine metabolism—TYR—skin cancer	0.116	0.584	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—GLI2—skin cancer	0.0258	0.13	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—GLI1—skin cancer	0.0243	0.122	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—SHH—skin cancer	0.0175	0.0885	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—NKX2-1—skin cancer	0.00662	0.0334	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—CDK4—skin cancer	0.00187	0.00942	CbGpPWpGaD
Carbidopa—Dyspepsia—Imiquimod—skin cancer	0.00177	0.0022	CcSEcCtD
Carbidopa—Decreased appetite—Imiquimod—skin cancer	0.00174	0.00217	CcSEcCtD
Carbidopa—Hot flush—Docetaxel—skin cancer	0.00174	0.00217	CcSEcCtD
Carbidopa—Flushing—Dactinomycin—skin cancer	0.00174	0.00216	CcSEcCtD
Carbidopa—Hypersensitivity—Vemurafenib—skin cancer	0.00173	0.00216	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Imiquimod—skin cancer	0.00173	0.00216	CcSEcCtD
Carbidopa—Fatigue—Imiquimod—skin cancer	0.00173	0.00216	CcSEcCtD
Carbidopa—Menopausal symptoms—Docetaxel—skin cancer	0.00172	0.00215	CcSEcCtD
Carbidopa—Pain—Imiquimod—skin cancer	0.00171	0.00214	CcSEcCtD
Carbidopa—Acute coronary syndrome—Fluorouracil—skin cancer	0.00171	0.00213	CcSEcCtD
Carbidopa—Neuropathy peripheral—Fluorouracil—skin cancer	0.0017	0.00212	CcSEcCtD
Carbidopa—Myocardial infarction—Fluorouracil—skin cancer	0.0017	0.00212	CcSEcCtD
Carbidopa—Dermatitis bullous—Docetaxel—skin cancer	0.0017	0.00212	CcSEcCtD
Carbidopa—Haemoglobin—Temozolomide—skin cancer	0.0017	0.00212	CcSEcCtD
Carbidopa—Haemorrhage—Temozolomide—skin cancer	0.00169	0.00211	CcSEcCtD
Carbidopa—Urinary tract infection—Fluorouracil—skin cancer	0.00169	0.0021	CcSEcCtD
Carbidopa—Asthenia—Vemurafenib—skin cancer	0.00169	0.0021	CcSEcCtD
Carbidopa—Hypoaesthesia—Temozolomide—skin cancer	0.00168	0.0021	CcSEcCtD
Carbidopa—Hallucination—Temozolomide—skin cancer	0.00168	0.0021	CcSEcCtD
Carbidopa—Urinary tract disorder—Temozolomide—skin cancer	0.00167	0.00208	CcSEcCtD
Carbidopa—Pruritus—Vemurafenib—skin cancer	0.00166	0.00207	CcSEcCtD
Carbidopa—Urethral disorder—Temozolomide—skin cancer	0.00166	0.00207	CcSEcCtD
Carbidopa—Alopecia—Dactinomycin—skin cancer	0.00165	0.00206	CcSEcCtD
Carbidopa—Feeling abnormal—Imiquimod—skin cancer	0.00165	0.00206	CcSEcCtD
Carbidopa—Gastrointestinal pain—Imiquimod—skin cancer	0.00164	0.00204	CcSEcCtD
Carbidopa—Hyponatraemia—Docetaxel—skin cancer	0.00163	0.00204	CcSEcCtD
Carbidopa—Pain in extremity—Docetaxel—skin cancer	0.00163	0.00203	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00163	0.00203	CcSEcCtD
Carbidopa—Agranulocytosis—Fluorouracil—skin cancer	0.00162	0.00202	CcSEcCtD
Carbidopa—Ill-defined disorder—Bleomycin—skin cancer	0.00162	0.00202	CcSEcCtD
Carbidopa—Anaemia—Bleomycin—skin cancer	0.00161	0.00201	CcSEcCtD
Carbidopa—Diarrhoea—Vemurafenib—skin cancer	0.00161	0.00201	CcSEcCtD
Carbidopa—Urticaria—Imiquimod—skin cancer	0.00159	0.00199	CcSEcCtD
Carbidopa—Abdominal pain—Imiquimod—skin cancer	0.00159	0.00198	CcSEcCtD
Carbidopa—Body temperature increased—Imiquimod—skin cancer	0.00159	0.00198	CcSEcCtD
Carbidopa—Malaise—Bleomycin—skin cancer	0.00157	0.00196	CcSEcCtD
Carbidopa—Flushing—Temozolomide—skin cancer	0.00157	0.00196	CcSEcCtD
Carbidopa—Haemoglobin—Fluorouracil—skin cancer	0.00157	0.00195	CcSEcCtD
Carbidopa—Leukopenia—Bleomycin—skin cancer	0.00156	0.00195	CcSEcCtD
Carbidopa—Rhinitis—Fluorouracil—skin cancer	0.00156	0.00195	CcSEcCtD
Carbidopa—Haemorrhage—Fluorouracil—skin cancer	0.00156	0.00194	CcSEcCtD
Carbidopa—Dizziness—Vemurafenib—skin cancer	0.00155	0.00194	CcSEcCtD
Carbidopa—Hypoaesthesia—Fluorouracil—skin cancer	0.00155	0.00193	CcSEcCtD
Carbidopa—Ataxia—Docetaxel—skin cancer	0.00153	0.00191	CcSEcCtD
Carbidopa—Cough—Bleomycin—skin cancer	0.00152	0.0019	CcSEcCtD
Carbidopa—Ill-defined disorder—Dactinomycin—skin cancer	0.00151	0.00188	CcSEcCtD
Carbidopa—Anaemia—Dactinomycin—skin cancer	0.0015	0.00188	CcSEcCtD
Carbidopa—Vomiting—Vemurafenib—skin cancer	0.0015	0.00186	CcSEcCtD
Carbidopa—Alopecia—Temozolomide—skin cancer	0.00149	0.00186	CcSEcCtD
Carbidopa—Chest pain—Bleomycin—skin cancer	0.00149	0.00185	CcSEcCtD
Carbidopa—Orthostatic hypotension—Docetaxel—skin cancer	0.00149	0.00185	CcSEcCtD
Carbidopa—Rash—Vemurafenib—skin cancer	0.00148	0.00185	CcSEcCtD
Carbidopa—Mental disorder—Temozolomide—skin cancer	0.00148	0.00185	CcSEcCtD
Carbidopa—Dermatitis—Vemurafenib—skin cancer	0.00148	0.00185	CcSEcCtD
Carbidopa—Hypersensitivity—Imiquimod—skin cancer	0.00148	0.00184	CcSEcCtD
Carbidopa—Headache—Vemurafenib—skin cancer	0.00147	0.00184	CcSEcCtD
Carbidopa—Discomfort—Bleomycin—skin cancer	0.00147	0.00183	CcSEcCtD
Carbidopa—Malaise—Dactinomycin—skin cancer	0.00147	0.00183	CcSEcCtD
Carbidopa—Cramp muscle—Docetaxel—skin cancer	0.00146	0.00183	CcSEcCtD
Carbidopa—Leukopenia—Dactinomycin—skin cancer	0.00146	0.00182	CcSEcCtD
Carbidopa—Nasopharyngitis—Docetaxel—skin cancer	0.00145	0.00181	CcSEcCtD
Carbidopa—Dysgeusia—Temozolomide—skin cancer	0.00144	0.0018	CcSEcCtD
Carbidopa—Asthenia—Imiquimod—skin cancer	0.00144	0.00179	CcSEcCtD
Carbidopa—Confusional state—Bleomycin—skin cancer	0.00144	0.00179	CcSEcCtD
Carbidopa—Oedema—Bleomycin—skin cancer	0.00142	0.00178	CcSEcCtD
Carbidopa—Back pain—Temozolomide—skin cancer	0.00142	0.00178	CcSEcCtD
Carbidopa—Pruritus—Imiquimod—skin cancer	0.00142	0.00177	CcSEcCtD
Carbidopa—Infection—Bleomycin—skin cancer	0.00142	0.00176	CcSEcCtD
Carbidopa—Dysphagia—Docetaxel—skin cancer	0.00141	0.00175	CcSEcCtD
Carbidopa—Nausea—Vemurafenib—skin cancer	0.0014	0.00174	CcSEcCtD
Carbidopa—Thrombocytopenia—Bleomycin—skin cancer	0.00139	0.00174	CcSEcCtD
Carbidopa—Vision blurred—Temozolomide—skin cancer	0.00139	0.00173	CcSEcCtD
Carbidopa—Tremor—Temozolomide—skin cancer	0.00138	0.00172	CcSEcCtD
Carbidopa—Alopecia—Fluorouracil—skin cancer	0.00138	0.00172	CcSEcCtD
Carbidopa—Diarrhoea—Imiquimod—skin cancer	0.00137	0.00171	CcSEcCtD
Carbidopa—Discomfort—Dactinomycin—skin cancer	0.00137	0.00171	CcSEcCtD
Carbidopa—Ill-defined disorder—Temozolomide—skin cancer	0.00137	0.0017	CcSEcCtD
Carbidopa—Anaemia—Temozolomide—skin cancer	0.00136	0.0017	CcSEcCtD
Carbidopa—Anorexia—Bleomycin—skin cancer	0.00136	0.00169	CcSEcCtD
Carbidopa—DDC—Metabolism—PLIN2—skin cancer	0.00135	0.00684	CbGpPWpGaD
Carbidopa—Agitation—Temozolomide—skin cancer	0.00135	0.00169	CcSEcCtD
Carbidopa—Angioedema—Temozolomide—skin cancer	0.00135	0.00168	CcSEcCtD
Carbidopa—Hypotension—Bleomycin—skin cancer	0.00133	0.00166	CcSEcCtD
Carbidopa—Oedema—Dactinomycin—skin cancer	0.00133	0.00166	CcSEcCtD
Carbidopa—Malaise—Temozolomide—skin cancer	0.00133	0.00166	CcSEcCtD
Carbidopa—Dizziness—Imiquimod—skin cancer	0.00133	0.00165	CcSEcCtD
Carbidopa—Infection—Dactinomycin—skin cancer	0.00132	0.00165	CcSEcCtD
Carbidopa—Leukopenia—Temozolomide—skin cancer	0.00132	0.00164	CcSEcCtD
Carbidopa—Palpitations—Temozolomide—skin cancer	0.0013	0.00162	CcSEcCtD
Carbidopa—Thrombocytopenia—Dactinomycin—skin cancer	0.0013	0.00162	CcSEcCtD
Carbidopa—Cough—Temozolomide—skin cancer	0.00128	0.0016	CcSEcCtD
Carbidopa—Paraesthesia—Bleomycin—skin cancer	0.00128	0.0016	CcSEcCtD
Carbidopa—Weight increased—Docetaxel—skin cancer	0.00128	0.00159	CcSEcCtD
Carbidopa—Vision blurred—Fluorouracil—skin cancer	0.00128	0.00159	CcSEcCtD
Carbidopa—Convulsion—Temozolomide—skin cancer	0.00128	0.00159	CcSEcCtD
Carbidopa—Vomiting—Imiquimod—skin cancer	0.00128	0.00159	CcSEcCtD
Carbidopa—Weight decreased—Docetaxel—skin cancer	0.00127	0.00159	CcSEcCtD
Carbidopa—Hypertension—Temozolomide—skin cancer	0.00127	0.00159	CcSEcCtD
Carbidopa—Dyspnoea—Bleomycin—skin cancer	0.00127	0.00158	CcSEcCtD
Carbidopa—Anorexia—Dactinomycin—skin cancer	0.00127	0.00158	CcSEcCtD
Carbidopa—Rash—Imiquimod—skin cancer	0.00126	0.00158	CcSEcCtD
Carbidopa—Dermatitis—Imiquimod—skin cancer	0.00126	0.00158	CcSEcCtD
Carbidopa—Headache—Imiquimod—skin cancer	0.00126	0.00157	CcSEcCtD
Carbidopa—Anaemia—Fluorouracil—skin cancer	0.00125	0.00156	CcSEcCtD
Carbidopa—Anxiety—Temozolomide—skin cancer	0.00125	0.00156	CcSEcCtD
Carbidopa—Discomfort—Temozolomide—skin cancer	0.00124	0.00154	CcSEcCtD
Carbidopa—Decreased appetite—Bleomycin—skin cancer	0.00124	0.00154	CcSEcCtD
Carbidopa—Acute coronary syndrome—Docetaxel—skin cancer	0.00124	0.00154	CcSEcCtD
Carbidopa—Neuropathy peripheral—Docetaxel—skin cancer	0.00123	0.00153	CcSEcCtD
Carbidopa—Myocardial infarction—Docetaxel—skin cancer	0.00123	0.00153	CcSEcCtD
Carbidopa—Dry mouth—Temozolomide—skin cancer	0.00123	0.00153	CcSEcCtD
Carbidopa—Pain—Bleomycin—skin cancer	0.00122	0.00152	CcSEcCtD
Carbidopa—Leukopenia—Fluorouracil—skin cancer	0.00121	0.00151	CcSEcCtD
Carbidopa—Confusional state—Temozolomide—skin cancer	0.00121	0.00151	CcSEcCtD
Carbidopa—Oedema—Temozolomide—skin cancer	0.0012	0.0015	CcSEcCtD
Carbidopa—Infection—Temozolomide—skin cancer	0.00119	0.00149	CcSEcCtD
Carbidopa—Nausea—Imiquimod—skin cancer	0.00119	0.00149	CcSEcCtD
Carbidopa—Thrombocytopenia—Temozolomide—skin cancer	0.00118	0.00147	CcSEcCtD
Carbidopa—Convulsion—Fluorouracil—skin cancer	0.00118	0.00147	CcSEcCtD
Carbidopa—Feeling abnormal—Bleomycin—skin cancer	0.00117	0.00146	CcSEcCtD
Carbidopa—Agranulocytosis—Docetaxel—skin cancer	0.00117	0.00146	CcSEcCtD
Carbidopa—Hyperhidrosis—Temozolomide—skin cancer	0.00116	0.00145	CcSEcCtD
Carbidopa—Chest pain—Fluorouracil—skin cancer	0.00116	0.00144	CcSEcCtD
Carbidopa—Decreased appetite—Dactinomycin—skin cancer	0.00115	0.00144	CcSEcCtD
Carbidopa—Fatigue—Dactinomycin—skin cancer	0.00115	0.00143	CcSEcCtD
Carbidopa—Anorexia—Temozolomide—skin cancer	0.00115	0.00143	CcSEcCtD
Carbidopa—Discomfort—Fluorouracil—skin cancer	0.00114	0.00142	CcSEcCtD
Carbidopa—Pain—Dactinomycin—skin cancer	0.00114	0.00142	CcSEcCtD
Carbidopa—Urticaria—Bleomycin—skin cancer	0.00113	0.00141	CcSEcCtD
Carbidopa—Haemoglobin—Docetaxel—skin cancer	0.00113	0.00141	CcSEcCtD
Carbidopa—Rhinitis—Docetaxel—skin cancer	0.00113	0.00141	CcSEcCtD
Carbidopa—Body temperature increased—Bleomycin—skin cancer	0.00113	0.0014	CcSEcCtD
Carbidopa—Haemorrhage—Docetaxel—skin cancer	0.00112	0.0014	CcSEcCtD
Carbidopa—Hypoaesthesia—Docetaxel—skin cancer	0.00112	0.0014	CcSEcCtD
Carbidopa—Confusional state—Fluorouracil—skin cancer	0.00112	0.00139	CcSEcCtD
Carbidopa—Urinary tract disorder—Docetaxel—skin cancer	0.00111	0.00139	CcSEcCtD
Carbidopa—Oedema—Fluorouracil—skin cancer	0.00111	0.00138	CcSEcCtD
Carbidopa—Urethral disorder—Docetaxel—skin cancer	0.0011	0.00137	CcSEcCtD
Carbidopa—Infection—Fluorouracil—skin cancer	0.0011	0.00137	CcSEcCtD
Carbidopa—Feeling abnormal—Dactinomycin—skin cancer	0.00109	0.00137	CcSEcCtD
Carbidopa—DDC—Metabolism—CSPG4—skin cancer	0.00109	0.00551	CbGpPWpGaD
Carbidopa—Insomnia—Temozolomide—skin cancer	0.00109	0.00136	CcSEcCtD
Carbidopa—Gastrointestinal pain—Dactinomycin—skin cancer	0.00109	0.00135	CcSEcCtD
Carbidopa—Thrombocytopenia—Fluorouracil—skin cancer	0.00108	0.00135	CcSEcCtD
Carbidopa—Paraesthesia—Temozolomide—skin cancer	0.00108	0.00135	CcSEcCtD
Carbidopa—Dyspnoea—Temozolomide—skin cancer	0.00107	0.00134	CcSEcCtD
Carbidopa—Somnolence—Temozolomide—skin cancer	0.00107	0.00133	CcSEcCtD
Carbidopa—Dyspepsia—Temozolomide—skin cancer	0.00106	0.00132	CcSEcCtD
Carbidopa—Anorexia—Fluorouracil—skin cancer	0.00106	0.00132	CcSEcCtD
Carbidopa—Abdominal pain—Dactinomycin—skin cancer	0.00105	0.00131	CcSEcCtD
Carbidopa—Body temperature increased—Dactinomycin—skin cancer	0.00105	0.00131	CcSEcCtD
Carbidopa—Hypersensitivity—Bleomycin—skin cancer	0.00105	0.00131	CcSEcCtD
Carbidopa—Decreased appetite—Temozolomide—skin cancer	0.00104	0.0013	CcSEcCtD
Carbidopa—Flushing—Docetaxel—skin cancer	0.00104	0.0013	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Temozolomide—skin cancer	0.00104	0.00129	CcSEcCtD
Carbidopa—Fatigue—Temozolomide—skin cancer	0.00104	0.00129	CcSEcCtD
Carbidopa—Hypotension—Fluorouracil—skin cancer	0.00103	0.00129	CcSEcCtD
Carbidopa—Pain—Temozolomide—skin cancer	0.00103	0.00128	CcSEcCtD
Carbidopa—Constipation—Temozolomide—skin cancer	0.00103	0.00128	CcSEcCtD
Carbidopa—Asthenia—Bleomycin—skin cancer	0.00102	0.00127	CcSEcCtD
Carbidopa—Pruritus—Bleomycin—skin cancer	0.00101	0.00126	CcSEcCtD
Carbidopa—Insomnia—Fluorouracil—skin cancer	0.001	0.00125	CcSEcCtD
Carbidopa—Paraesthesia—Fluorouracil—skin cancer	0.000994	0.00124	CcSEcCtD
Carbidopa—Alopecia—Docetaxel—skin cancer	0.000994	0.00124	CcSEcCtD
Carbidopa—Feeling abnormal—Temozolomide—skin cancer	0.00099	0.00123	CcSEcCtD
Carbidopa—Dyspnoea—Fluorouracil—skin cancer	0.000987	0.00123	CcSEcCtD
Carbidopa—Mental disorder—Docetaxel—skin cancer	0.000985	0.00123	CcSEcCtD
Carbidopa—Somnolence—Fluorouracil—skin cancer	0.000984	0.00123	CcSEcCtD
Carbidopa—Gastrointestinal pain—Temozolomide—skin cancer	0.000983	0.00123	CcSEcCtD
Carbidopa—Hypersensitivity—Dactinomycin—skin cancer	0.000979	0.00122	CcSEcCtD
Carbidopa—Dyspepsia—Fluorouracil—skin cancer	0.000975	0.00122	CcSEcCtD
Carbidopa—Decreased appetite—Fluorouracil—skin cancer	0.000963	0.0012	CcSEcCtD
Carbidopa—Dysgeusia—Docetaxel—skin cancer	0.000959	0.0012	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000956	0.00119	CcSEcCtD
Carbidopa—Urticaria—Temozolomide—skin cancer	0.000955	0.00119	CcSEcCtD
Carbidopa—Asthenia—Dactinomycin—skin cancer	0.000953	0.00119	CcSEcCtD
Carbidopa—Abdominal pain—Temozolomide—skin cancer	0.00095	0.00118	CcSEcCtD
Carbidopa—Body temperature increased—Temozolomide—skin cancer	0.00095	0.00118	CcSEcCtD
Carbidopa—Back pain—Docetaxel—skin cancer	0.000947	0.00118	CcSEcCtD
Carbidopa—Pain—Fluorouracil—skin cancer	0.000947	0.00118	CcSEcCtD
Carbidopa—Muscle spasms—Docetaxel—skin cancer	0.000941	0.00117	CcSEcCtD
Carbidopa—Feeling abnormal—Fluorouracil—skin cancer	0.000912	0.00114	CcSEcCtD
Carbidopa—Diarrhoea—Dactinomycin—skin cancer	0.000909	0.00113	CcSEcCtD
Carbidopa—Vomiting—Bleomycin—skin cancer	0.000906	0.00113	CcSEcCtD
Carbidopa—Anaemia—Docetaxel—skin cancer	0.000905	0.00113	CcSEcCtD
Carbidopa—Rash—Bleomycin—skin cancer	0.000898	0.00112	CcSEcCtD
Carbidopa—Dermatitis—Bleomycin—skin cancer	0.000897	0.00112	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL6—skin cancer	0.00089	0.00449	CbGpPWpGaD
Carbidopa—Hypersensitivity—Temozolomide—skin cancer	0.000885	0.0011	CcSEcCtD
Carbidopa—Urticaria—Fluorouracil—skin cancer	0.00088	0.0011	CcSEcCtD
Carbidopa—Syncope—Docetaxel—skin cancer	0.000878	0.00109	CcSEcCtD
Carbidopa—Leukopenia—Docetaxel—skin cancer	0.000877	0.00109	CcSEcCtD
Carbidopa—Body temperature increased—Fluorouracil—skin cancer	0.000875	0.00109	CcSEcCtD
Carbidopa—Palpitations—Docetaxel—skin cancer	0.000865	0.00108	CcSEcCtD
Carbidopa—Asthenia—Temozolomide—skin cancer	0.000862	0.00108	CcSEcCtD
Carbidopa—Loss of consciousness—Docetaxel—skin cancer	0.000861	0.00107	CcSEcCtD
Carbidopa—Cough—Docetaxel—skin cancer	0.000854	0.00107	CcSEcCtD
Carbidopa—Pruritus—Temozolomide—skin cancer	0.00085	0.00106	CcSEcCtD
Carbidopa—Convulsion—Docetaxel—skin cancer	0.000848	0.00106	CcSEcCtD
Carbidopa—Nausea—Bleomycin—skin cancer	0.000846	0.00106	CcSEcCtD
Carbidopa—Hypertension—Docetaxel—skin cancer	0.000845	0.00105	CcSEcCtD
Carbidopa—Vomiting—Dactinomycin—skin cancer	0.000845	0.00105	CcSEcCtD
Carbidopa—Rash—Dactinomycin—skin cancer	0.000838	0.00104	CcSEcCtD
Carbidopa—Chest pain—Docetaxel—skin cancer	0.000834	0.00104	CcSEcCtD
Carbidopa—Diarrhoea—Temozolomide—skin cancer	0.000822	0.00103	CcSEcCtD
Carbidopa—Hypersensitivity—Fluorouracil—skin cancer	0.000816	0.00102	CcSEcCtD
Carbidopa—Dry mouth—Docetaxel—skin cancer	0.000815	0.00102	CcSEcCtD
Carbidopa—Confusional state—Docetaxel—skin cancer	0.000806	0.001	CcSEcCtD
Carbidopa—Oedema—Docetaxel—skin cancer	0.000799	0.000997	CcSEcCtD
Carbidopa—Dizziness—Temozolomide—skin cancer	0.000795	0.000991	CcSEcCtD
Carbidopa—Infection—Docetaxel—skin cancer	0.000794	0.00099	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—TP53—skin cancer	0.000794	0.00401	CbGpPWpGaD
Carbidopa—Nausea—Dactinomycin—skin cancer	0.000789	0.000984	CcSEcCtD
Carbidopa—Shock—Docetaxel—skin cancer	0.000786	0.00098	CcSEcCtD
Carbidopa—Pruritus—Fluorouracil—skin cancer	0.000783	0.000977	CcSEcCtD
Carbidopa—Thrombocytopenia—Docetaxel—skin cancer	0.000782	0.000976	CcSEcCtD
Carbidopa—Vomiting—Temozolomide—skin cancer	0.000764	0.000953	CcSEcCtD
Carbidopa—Anorexia—Docetaxel—skin cancer	0.000762	0.00095	CcSEcCtD
Carbidopa—Rash—Temozolomide—skin cancer	0.000758	0.000945	CcSEcCtD
Carbidopa—Diarrhoea—Fluorouracil—skin cancer	0.000758	0.000945	CcSEcCtD
Carbidopa—Dermatitis—Temozolomide—skin cancer	0.000757	0.000944	CcSEcCtD
Carbidopa—Headache—Temozolomide—skin cancer	0.000753	0.000939	CcSEcCtD
Carbidopa—Hypotension—Docetaxel—skin cancer	0.000747	0.000931	CcSEcCtD
Carbidopa—DDC—Metabolism—ENO2—skin cancer	0.000742	0.00375	CbGpPWpGaD
Carbidopa—Dizziness—Fluorouracil—skin cancer	0.000732	0.000913	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—IL6—skin cancer	0.000727	0.00367	CbGpPWpGaD
Carbidopa—Insomnia—Docetaxel—skin cancer	0.000723	0.000901	CcSEcCtD
Carbidopa—Paraesthesia—Docetaxel—skin cancer	0.000718	0.000895	CcSEcCtD
Carbidopa—Nausea—Temozolomide—skin cancer	0.000714	0.00089	CcSEcCtD
Carbidopa—Dyspnoea—Docetaxel—skin cancer	0.000712	0.000888	CcSEcCtD
Carbidopa—Somnolence—Docetaxel—skin cancer	0.00071	0.000886	CcSEcCtD
Carbidopa—Vomiting—Fluorouracil—skin cancer	0.000704	0.000878	CcSEcCtD
Carbidopa—Dyspepsia—Docetaxel—skin cancer	0.000703	0.000877	CcSEcCtD
Carbidopa—Rash—Fluorouracil—skin cancer	0.000698	0.000871	CcSEcCtD
Carbidopa—Dermatitis—Fluorouracil—skin cancer	0.000697	0.00087	CcSEcCtD
Carbidopa—Decreased appetite—Docetaxel—skin cancer	0.000695	0.000866	CcSEcCtD
Carbidopa—Headache—Fluorouracil—skin cancer	0.000694	0.000865	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Docetaxel—skin cancer	0.00069	0.00086	CcSEcCtD
Carbidopa—Fatigue—Docetaxel—skin cancer	0.000689	0.000859	CcSEcCtD
Carbidopa—Constipation—Docetaxel—skin cancer	0.000683	0.000852	CcSEcCtD
Carbidopa—Pain—Docetaxel—skin cancer	0.000683	0.000852	CcSEcCtD
Carbidopa—Feeling abnormal—Docetaxel—skin cancer	0.000659	0.000821	CcSEcCtD
Carbidopa—Nausea—Fluorouracil—skin cancer	0.000658	0.00082	CcSEcCtD
Carbidopa—Gastrointestinal pain—Docetaxel—skin cancer	0.000653	0.000815	CcSEcCtD
Carbidopa—Abdominal pain—Docetaxel—skin cancer	0.000632	0.000788	CcSEcCtD
Carbidopa—Body temperature increased—Docetaxel—skin cancer	0.000632	0.000788	CcSEcCtD
Carbidopa—Hypersensitivity—Docetaxel—skin cancer	0.000589	0.000734	CcSEcCtD
Carbidopa—Asthenia—Docetaxel—skin cancer	0.000573	0.000715	CcSEcCtD
Carbidopa—Pruritus—Docetaxel—skin cancer	0.000565	0.000705	CcSEcCtD
Carbidopa—Diarrhoea—Docetaxel—skin cancer	0.000547	0.000682	CcSEcCtD
Carbidopa—Dizziness—Docetaxel—skin cancer	0.000528	0.000659	CcSEcCtD
Carbidopa—Vomiting—Docetaxel—skin cancer	0.000508	0.000634	CcSEcCtD
Carbidopa—Rash—Docetaxel—skin cancer	0.000504	0.000628	CcSEcCtD
Carbidopa—Dermatitis—Docetaxel—skin cancer	0.000503	0.000628	CcSEcCtD
Carbidopa—Headache—Docetaxel—skin cancer	0.000501	0.000624	CcSEcCtD
Carbidopa—Nausea—Docetaxel—skin cancer	0.000475	0.000592	CcSEcCtD
Carbidopa—DDC—Metabolism—ERCC2—skin cancer	0.000431	0.00218	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTGS2—skin cancer	0.000258	0.0013	CbGpPWpGaD
